Relexxii Tablet, Extended Release
Product Images NDC 68025-096

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Relexxii (NDC 68025-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vertical Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Relexxii Structural Formula (Relexxii Methylphenidate Hydrochloride Extended Re 1)

Chemical structure of methylphenidate hydrochloride, the active ingredient in RELEXXII. The diagram shows the molecular configuration including a piperidine ring and phenyl group with associated functional groups.*

FDA Label Image

Relexxii 63 mg 100ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 10)

RELEXXII 63 mg extended-release tablets labeled for oral use containing methylphenidate hydrochloride. The label includes dosage strength (63 mg), packaging quantity (100 tablets), and distributor information (Vertical Pharmaceuticals, LLC, Alpharetta, GA). Storage instructions note keeping the package child-resistant and storing at 20° to 25°C. The label also features the NDC 68025-089-10 and a barcode.*

FDA Label Image

Figure 1 (Relexxii Methylphenidate Hydrochloride Extended Re 2)

A line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) between methylphenidate HCl extended-release tablets 18 mg once daily and methylphenidate 5 mg taken three times daily. The graph shows plasma concentration trends from 0 to 32 hours, illustrating the pharmacokinetic profiles of the two dosing regimens.*

FDA Label Image

Figure 2 (Relexxii Methylphenidate Hydrochloride Extended Re 3)

A bar chart comparing maximum symptoms of inattention/overactivity scale between methylphenidate hydrochloride extended-release tablets once daily and placebo across three studies. Each study shows symptom levels with black bars for the drug and white bars for placebo, indicating lower symptom scores with methylphenidate hydrochloride in all studies including Study 3 at Week 4.*

FDA Label Image

Figure 3 (Relexxii Methylphenidate Hydrochloride Extended Re 4)

A line graph comparing attention levels over 12 hours post initial dose between methylphenidate hydrochloride extended-release tablets and placebo. The vertical axis measures combined attention on a scale where lower values indicate more attentive. Two lines show methylphenidate and placebo groups, with methylphenidate consistently showing better attention. Sample sizes and error bars are included.*

FDA Label Image

Vertical Logo (Relexxii Methylphenidate Hydrochloride Extended Re 5)

FDA Label Image

Vertical Logo (Relexxii Methylphenidate Hydrochloride Extended Re 6)

FDA Label Image

Relexxii 45 mg 30ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 7)

Label for RELEXXII 45 mg extended-release tablets, methylphenidate hydrochloride. The label includes dosage strength, quantity of 30 tablets, manufacturer details (Vertical Pharmaceuticals, LLC), and storage instructions. It states the product is prescription only and includes a barcode with the NDC 68025-088-30.*

FDA Label Image

Relexxii 45 mg 100ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 8)

Label for RELEXXII 45 mg extended-release tablets containing methylphenidate hydrochloride. The label includes dosage form, strength, manufacturer Vertical Pharmaceuticals, LLC, a barcode, and storage instructions. The package contains 100 tablets and is prescription only.*

FDA Label Image

Relexxii 63 mg 30ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 9)

Label for RELEXXII 63 mg extended-release tablets containing methylphenidate hydrochloride. The label includes dosage strength, NDC 68025-089-30, a barcode, and packaging details. It indicates the product is dispensed by Vertical Pharmaceuticals, LLC in Alpharetta, GA, contains 30 tablets, and is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.